These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 22107803)

  • 1. Extracorporeal shockwave myocardial revascularization improves clinical symptoms and left ventricular function in patients with refractory angina.
    Zuozienė G; Laucevičius A; Leibowitz D
    Coron Artery Dis; 2012 Jan; 23(1):62-7. PubMed ID: 22107803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The beneficial effect of extracorporeal shockwave myocardial revascularization in patients with refractory angina.
    Alunni G; Marra S; Meynet I; D'amico M; Elisa P; Fanelli A; Molinaro S; Garrone P; Deberardinis A; Campana M; Lerman A
    Cardiovasc Revasc Med; 2015; 16(1):6-11. PubMed ID: 25555620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracorporeal shockwave myocardial therapy is efficacious in improving symptoms in patients with refractory angina pectoris--a multicenter study.
    Prasad M; Wan Ahmad WA; Sukmawan R; Magsombol EB; Cassar A; Vinshtok Y; Ismail MD; Mahmood Zuhdi AS; Locnen SA; Jimenez R; Callleja H; Lerman A
    Coron Artery Dis; 2015 May; 26(3):194-200. PubMed ID: 25734606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness and Safety of Extracorporeal Shockwave Myocardial Revascularization in Patients With Refractory Angina Pectoris and Heart Failure.
    Martínez-Sánchez C; Azar-Manzur F; González-Pacheco H; Amezcua-Guerra LM; Massó F; Márquez-Velasco R; Bojalil R; Carvajal-Juárez I; Alexanderson-Rosas E; Hernández S; Paez-Arenas A; López-Mora E; Venegas-Román A; Brianza-Padilla M; Gopar-Nieto R; Sandoval J
    Am J Cardiol; 2021 Apr; 144():26-32. PubMed ID: 33385348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of extracorporeal shock wave myocardial revascularization therapy for refractory angina pectoris.
    Cassar A; Prasad M; Rodriguez-Porcel M; Reeder GS; Karia D; DeMaria AN; Lerman A
    Mayo Clin Proc; 2014 Mar; 89(3):346-54. PubMed ID: 24582193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The beneficial effect of extracorporeal shockwave myocardial revascularization: Two years of follow-up.
    Alunni G; Barbero U; Vairo A; D'Amico S; Pianelli M; Zema D; Bongiovanni F; Gaita F
    Cardiovasc Revasc Med; 2017 Dec; 18(8):572-576. PubMed ID: 28622968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting long-term functional results after myocardial revascularization in ischemic cardiomyopathy.
    Luciani GB; Montalbano G; Casali G; Mazzucco A
    J Thorac Cardiovasc Surg; 2000 Sep; 120(3):478-89. PubMed ID: 10962408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous transmyocardial revascularization with holmium laser in patients with refractory angina: a pilot feasibility study.
    Galli M; Zerboni S; Politi A; Llambro M; Bonatti R; Molteni S; Ferrari G
    G Ital Cardiol; 1999 Sep; 29(9):1020-6. PubMed ID: 10514960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness and safety of percutaneous myocardial laser revascularization for refractory angina pectoris.
    Salem M; Rotevatn S; Stavnes S; Brekke M; Vollset SE; Nordrehaug JE
    Am J Cardiol; 2004 May; 93(9):1086-91. PubMed ID: 15110197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility of Extracorporeal Shock Wave Myocardial Revascularization Therapy for Post-Acute Myocardial Infarction Patients and Refractory Angina Pectoris Patients.
    Myojo M; Ando J; Uehara M; Daimon M; Watanabe M; Komuro I
    Int Heart J; 2017 Apr; 58(2):185-190. PubMed ID: 28320996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multicenter trial of extracorporeal cardiac shock wave therapy for refractory angina pectoris: report of the highly advanced medical treatment in Japan.
    Kikuchi Y; Ito K; Shindo T; Hao K; Shiroto T; Matsumoto Y; Takahashi J; Matsubara T; Yamada A; Ozaki Y; Hiroe M; Misumi K; Ota H; Takanami K; Hiraide T; Takase K; Tanji F; Tomata Y; Tsuji I; Shimokawa H
    Heart Vessels; 2019 Jan; 34(1):104-113. PubMed ID: 29942978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical predictors of left ventricular function improvement after percutaneous coronary interventions in patients with ejection fraction below 45%].
    Dudek D; Rzeszutko Ł; Turek P; Sorysz D; Dubiel JS
    Przegl Lek; 2001; 58(7-8):751-4. PubMed ID: 11769380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracorporeal shockwave myocardial revascularization therapy in refractory angina patients.
    Slavich M; Ancona F; Margonato A
    Int J Cardiol; 2015 Sep; 194():93. PubMed ID: 26011274
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of magnetic resonance imaging to assess myocardial perfusion after transmyocardial laser revascularization.
    Akay MH; Cheong BY; Frazier OH
    Heart Surg Forum; 2009 Aug; 12(4):E199-201. PubMed ID: 19683988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracorporeal myocardial shockwave therapy; a precious blast for refractory angina patients.
    Slavich M; Pizzetti G; Vella AM; Carlucci C; Margonato D; Spoladore R; Fragasso G; Margonato A
    Cardiovasc Revasc Med; 2018 Apr; 19(3 Pt A):263-267. PubMed ID: 29122526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term prognosis in stable angina; medical treatment or coronary revascularization in patients younger than 70 years?
    Carpeggiani C; Landi P; Michelassi C; Barberini E; L'Abbate A
    Int J Cardiol; 2011 Apr; 148(1):43-7. PubMed ID: 19913308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of extracorporeal shockwave myocardial revascularization on the ischemic burden of refractory angina patients: a single photon emission computed tomography study.
    Alunni G; D'''''Amico S; Castelli C; De Lio G; Fioravanti F; Gallone G; Marra S; De Ferrari GM
    Minerva Cardioangiol; 2020 Dec; 68(6):567-576. PubMed ID: 32319266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronary sinus reducer stent for the treatment of chronic refractory angina pectoris: a prospective, open-label, multicenter, safety feasibility first-in-man study.
    Banai S; Ben Muvhar S; Parikh KH; Medina A; Sievert H; Seth A; Tsehori J; Paz Y; Sheinfeld A; Keren G
    J Am Coll Cardiol; 2007 May; 49(17):1783-9. PubMed ID: 17466229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of transmyocardial revascularization with medical therapy in patients with refractory angina.
    Allen KB; Dowling RD; Fudge TL; Schoettle GP; Selinger SL; Gangahar DM; Angell WW; Petracek MR; Shaar CJ; O'Neill WW
    N Engl J Med; 1999 Sep; 341(14):1029-36. PubMed ID: 10502592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Left ventricular systolic function in patients with refractory angina pectoris treated with percutaneous myocardial laser revascularisation, results of long-term follow-up].
    Zmudka K; Trebacz J; Podolec P; Olszowska M; Hlawaty M; Kostkiewicz M; Rudziński P; Sadowski J; Tracz W; Dudek D; Dubiel J
    Przegl Lek; 2004; 61(6):700-4. PubMed ID: 15724667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.